Optimal management of coronary artery disease in cancer patients

作     者：Xue-Jie Han Jian-Qiang Li Zulfiia Khannanova Yue Li Han Xue-Jie;Li Jian-Qiang;Khannanova Zulfiia;Li Yue

作者机构：Department of CardiologyThe First Affiliated Hospital of Harbin Medical UniversityHarbin Medical UniversityHarbinHeilongjiang 150001China Bashkir State Medical UniversityUfaRepublic BashkortostanRussia 

出 版 物：《Chronic Diseases and Translational Medicine》 (慢性疾病与转化医学（英文版）)

年 卷 期：2019年第5卷第4期

页      面：221-233页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：This work was supported by a grant from the National Natural Science Foundation of China(No.81830012) 

主　　题：Cancer Coronary artery disease Cardio-oncology 

摘      要：Owing to early diagnosis and rapid development of treatments for cancers,the five-year survival rate of all cancer types has markedly improved *** time,however,there has been an increase in the number of cancer patients who develop coronary artery disease(CAD)due to different ***,many risk factors are shared between cancer and ***,inflammation and oxidative stress are common underlying pathogeneses in both ***,cancer therapy can result in endothelial injury,coronary artery spasm,and coagulation,thereby increasing the risk of *** more cancer patients are being diagnosed with CAD,specialized cardiac care should be established to minimize the cardiovascular mortality of cancer survivors.